Although FoxP3+ Treg frequencies did not differ significantly between cohorts, they tended to be higher in patients with severe disease, which was consistent with previous reports of elevated circulating FoxP3+ Tregs in severe COVID-19 cases (55). This evidence concerns the gene FOXP3 and COVID-19.